Even if the Orphan Drug Act were working properly, its enormous costs might outweigh its exiguous benefits. But it’s not working properly. Drug manufacturers are gaming the Act in at least three important ways. They’re the topic of this week’s Healthcare Triage.
Tag Archives: Orphan Drug Act
Prescription drug spending surges amid market forces
AHA furious over ruling to exclude ‘orphan’ drugs from 340B program



